{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":1,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":21,"n_cols":5,"rows_kept":21,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[3,2,3,3],[5,2,5,3],[6,2,6,3],[7,2,7,3],[8,2,8,3],[11,2,11,3],[12,2,12,3],[16,2,16,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA9910464781803321"]
[null,null,"Titolo",null,"Evidence-based management of diabetes / / [edited by] Jiten Vora, John Buse"]
[null,null,"Pubbl/distr/stampa",null,"Harley : , : tfm Publishing, , 2012"]
[null,null,"ISBN",null,"1-908986-69-7"]
[{"$nulls":4},"1-908986-71-9"]
[null,null,"Edizione",null,"[First edition.]"]
[null,null,"Descrizione fisica",null,"1 online resource (520 p.)"]
[null,null,"Disciplina",null,"616.4/62"]
[null,null,"Soggetti",null,"Diabetes - Treatment"]
[{"$nulls":4},"Evidence-based medicine"]
[{"$nulls":4},"Electronic books."]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","Description based upon print version of record."]
[null,null,null,"Nota di bibliografia","Includes bibliographical references and index."]
[null,null,"Nota di contenuto",null,"\"\"COVER FRONT\"\"; \"\"Contents\"\"; \"\"Foreword\"\"; \"\"Contributors\"\"; \"\"Acknowledgements\"\"; \"\"Using evidence-based medicine\"\"; \"\"Chapter 1 Where does insulin resistance start;  contribution to the development of diabetes?\"\"; \"\"Chapter 2 Genetics studies in diabetes â€? how do they help?\"\"; \"\"Chapter 3 Prevention of type 2 diabetes in high-risk individuals: achievable?\"\"; \"\"Chapter 4 The glucocentric approach to diabetes care\"\"; \"\"Chapter 5 Supplying the missing link in diabetes care: evidence-based structured education for people with type 2 diabetes\"\""]
[{"$nulls":4},"\"\"Chapter 6 The role of blood glucose monitoring in type 2 diabetes a plea for common sense?\"\"; \"\"Chapter 7 The role of continuous glucose monitoring in the management of type 1 and type 2 diabetes\"\"; \"\"Chapter 8 Treatment of diabetes through targeting weight loss\"\"; \"\"Chapter 9 Weight loss therapies in diabetes â€? is there a future?\"\"; \"\"Chapter 10 Goals of treatment in type 2 diabetes mellitus: Î²-cell preservation\"\"; \"\"Chapter 11 Early insulin initiation in type 2 diabetes\"\"; \"\"Chapter 12 Immune intervention in type 1 diabetes\"\""]
[{"$nulls":4},"\"\"Chapter 13 Pancreas and islet transplantation: an evidence-based analysis\"\"\"\"Chapter 14 Hypoglycemia in type 2 diabetes: does it matter?\"\"; \"\"Chapter 15 Mental illness and diabetes â€? intricate interplay\"\"; \"\"Chapter 16 Diabetes treatments and cancer\"\"; \"\"Chapter 17 Screening for diabetic retinopathy\"\"; \"\"Chapter 18 Medical therapies for diabetic eye disease â€? how good are they?\"\"; \"\"Chapter 19 Diabetic neuropathic pain â€? assessment and treatment\"\"; \"\"Chapter 20 The "]
[{"$nulls":4},"diabetic foot: where are we?\"\""]
[{"$nulls":4},"\"\"Chapter 21 Non-alcoholic fatty liver disease (NAFLD) in diabetes: distraction or impending disaster?\"\"\"\"Chapter 22 Management of kidney risk in diabetes\"\"; \"\"Chapter 23 Use of dual RAAS blockade in diabetic nephropathy\"\"; \"\"Chapter 24 Glucose control and macrovascular disease/morbidity\"\"; \"\"Chapter 25 Hyperglycemia in acute coronary syndromes\"\"; \"\"Chapter 26 Screening for coronary artery disease in patients with type 2 diabetes\"\"; \"\"Index\"\"; \"\"COVER BACK\"\""]